162 related articles for article (PubMed ID: 21561306)
1. Bisphosphonate-associated atypical fracture of the femur: Spontaneous healing with drug holiday and re-appearance after resumed drug therapy with bilateral simultaneous displaced fractures--a case report.
Puah KL; Tan MH
Acta Orthop; 2011 Jun; 82(3):380-2. PubMed ID: 21561306
[No Abstract] [Full Text] [Related]
2. Histology of an undisplaced femoral fatigue fracture in association with bisphosphonate treatment. Frozen bone with remodelling at the crack.
Aspenberg P; Schilcher J; Fahlgren A
Acta Orthop; 2010 Aug; 81(4):460-2. PubMed ID: 20515438
[No Abstract] [Full Text] [Related]
3. Femoral canal obliteration secondary to prolonged alendronate use: a case report.
Lim CT; Setiobudi T; Das De S
J Orthop Surg (Hong Kong); 2012 Apr; 20(1):115-7. PubMed ID: 22535826
[TBL] [Abstract][Full Text] [Related]
4. Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.
Bögl HP; Aspenberg P; Schilcher J
Osteoporos Int; 2017 Aug; 28(8):2439-2444. PubMed ID: 28474166
[TBL] [Abstract][Full Text] [Related]
5. A rational approach to management of alendronate-related subtrochanteric fractures.
Das De S; Setiobudi T; Shen L; Das De S
J Bone Joint Surg Br; 2010 May; 92(5):679-86. PubMed ID: 20436006
[TBL] [Abstract][Full Text] [Related]
6. [Biphosphonate treatment can cause stress fracture. But treatment benefits significantly overweight the risk].
Sjödén G; Sayed-Noor A; Kadum B; Pettersson U
Lakartidningen; 2010 Oct 13-19; 107(41):2482-3. PubMed ID: 21137565
[No Abstract] [Full Text] [Related]
7. Obliteration of the medullary canal in an atypical bisphosphonate-related femoral fracture.
Cawley DT; Barrett HL; Harrington P
BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25568263
[TBL] [Abstract][Full Text] [Related]
8. Alendronate-related femoral diaphysis fracture--what should be done to predict and prevent subsequent fracture of the contralateral side?
Edwards MH; McCrae FC; Young-Min SA
Osteoporos Int; 2010 Apr; 21(4):701-3. PubMed ID: 19562241
[TBL] [Abstract][Full Text] [Related]
9. Long-term radiographic follow-up of bisphosphonate-associated atypical femur fractures.
Favinger JL; Hippe D; Ha AS
Skeletal Radiol; 2016 May; 45(5):627-33. PubMed ID: 26880003
[TBL] [Abstract][Full Text] [Related]
10. Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy?
Ha YC; Cho MR; Park KH; Kim SY; Koo KH
Clin Orthop Relat Res; 2010 Dec; 468(12):3393-8. PubMed ID: 20865463
[TBL] [Abstract][Full Text] [Related]
11. Alendronate-associated femoral insufficiency fractures and femoral stress reactions.
Wang K; Moaveni A; Dowrick A; Liew S
J Orthop Surg (Hong Kong); 2011 Apr; 19(1):89-92. PubMed ID: 21519086
[TBL] [Abstract][Full Text] [Related]
12. Atypical femoral fractures bilaterally in a patient receiving denosumab.
Drampalos E; Skarpas G; Barbounakis N; Michos I
Acta Orthop; 2014 Feb; 85(1):3-5. PubMed ID: 24171686
[No Abstract] [Full Text] [Related]
13. Femoral insufficiency fractures with bisphosphonate therapy. Cases study.
Boszczyk A; Kowalski D; Zakrzewski P; Pomianowski S
Ortop Traumatol Rehabil; 2011; 13(4):403-8. PubMed ID: 21857071
[TBL] [Abstract][Full Text] [Related]
14. Implant failure caused by non-union of bisphosphonate-associated subtrochanteric femur fracture.
O'Neill BJ; O'hEireamhoin S; Morrissey DI; Keogh P
BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24700046
[TBL] [Abstract][Full Text] [Related]
15. Pseudoarthrosis in atypical femoral fracture: case report.
Giannotti S; Bottai V; Dell'Osso G; De Paola G; Ghilardi M; Guido G
Osteoporos Int; 2013 Nov; 24(11):2893-5. PubMed ID: 23681089
[TBL] [Abstract][Full Text] [Related]
16. Case reports: subtrochanteric femoral stress fractures after prolonged alendronate therapy.
Cermak K; Shumelinsky F; Alexiou J; Gebhart MJ
Clin Orthop Relat Res; 2010 Jul; 468(7):1991-6. PubMed ID: 20020334
[TBL] [Abstract][Full Text] [Related]
17. Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy-a long-term radiological follow-up.
Png MA; Mohan PC; Koh JSB; Howe CY; Howe TS
Osteoporos Int; 2019 Dec; 30(12):2417-2428. PubMed ID: 31435684
[TBL] [Abstract][Full Text] [Related]
18. A Scapular Spine Fracture Defined on the Basis of a Bisphosphonate: a Case Report and Review of the Literature.
Ilyas G; Senyuva G
Acta Chir Orthop Traumatol Cech; 2022; 89(4):312-314. PubMed ID: 36055673
[TBL] [Abstract][Full Text] [Related]
19. Treatment of femoral fracture nonunion after long-term bisphosphonate use.
Grady MK; Watson JT; Cannada LK
Orthopedics; 2012 Jun; 35(6):e991-5. PubMed ID: 22691683
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review.
Selga J; Nuñez JH; Minguell J; Lalanza M; Garrido M
Osteoporos Int; 2016 Feb; 27(2):827-32. PubMed ID: 26501556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
